Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosageChun‐Jen Liu, Pei‐Jer Chen, Po‐Huang Lee et al.|Journal of Hepatology|2009Cited by 157
Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinomaRey‐Heng Hu, Po‐Huang Lee, Ming‐Chih Ho et al.|Clinical Transplantation|2005Cited by 52
Risk factors for neonatal early-onset group B streptococcus-related diseases after the implementation of a universal screening program in TaiwanLi‐Chen Hung, Wen‐Chen Tsai, Pei‐Tseng Kung et al.|BMC Public Health|2018Cited by 21
Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium‐90 resin microspheres in Taiwan: data from the RESIN registryRheun‐Chuan Lee, Chien‐Hung Chen, Hsueh‐Chou Lai et al.|Journal of Gastroenterology and Hepatology|2024Cited by 3